advertisement
3.8 Pharmacology (11)
Showing records 1 to 11
Display all abstracts in classification 3.8 Pharmacology
Search within classification 3.8 Pharmacology51986 Black Currant Anthocyanins Normalized Abnormal Levels of Serum Concentrations of Endothelin-1 in Patients with Glaucoma
Yoshida K; Ohguro I; Ohguro H
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 480-487
51764 Discovery of novel human aquaporin-1 blockers
Seeliger D; Zapater C; Krenc D; Haddoub R; Flitsch S; Beitz E; Cerdà J; de Groot BL
ACS Chemical Biology 2013; 8: 249-256
51677 Protective effects of 7,8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress
Gupta VK; You Y; Li JC; Klistorner A; Graham SL
Journal of Molecular Neuroscience 2013; 49: 96-104
51809 Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma
Pinazo-Durán MD; Zanón-Moreno V; García-Medina JJ; Gallego-Pinazo R
Current opinion in pharmacology 2013; 13: 98-107
51769 Taurine provides neuroprotection against retinal ganglion cell degeneration
Froger N; Cadetti L; Lorach H; Martins J; Bemelmans AP; Dubus E; Degardin J; Pain D; Forster V; Chicaud L; Ivkovic I; Simonutti M; Fouquet S; Jammoul F; Léveillard T; Benosman R; Sahel JA; Picaud S
PLoS ONE 2012; 7: e42017
51855 Neurogenic contractions in intraocular porcine ciliary arteries are mediated by α₂-adrenoceptors and NPY₁ receptors and are inhibited by prostaglandin E₂ acting on prejunctional EP₄ receptors
Kringelholt S; Simonsen U; Bek T
Experimental Eye Research 2013; 107: 32-36
52046 A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma
Long DD; Frieman B; Hegde SS; Hill CM; Jiang L; Kintz S; Marquess DG; Purkey H; Shaw JP; Steinfeld T; Wilson MS; Wrench K
Bioorganic and Medicinal Chemistry Letters 2013; 23: 939-943
51754 Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
Pertwee RG
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2012; 367: 3353-3363
52002 Effects of roscovitine, a cell cycling-dependent kinase inhibitor, on intraocular pressure of rabbit and retinal ganglion cell damage
Kasai H; Imamura T; Tsuruma K; Takahashi Y; Kurasawa T; Hirata H; Shimazawa M; Hara H
Neuroscience Letters 2013; 535: 95-99
52074 Intraocular pressure-lowering effect of oral paracetamol and its in vitro corneal penetration properties
Mohamed N; Meyer D
Clinical Ophthalmology 2013; 7: 219-227
51826 New developments in the pharmacological modulation of wound healing after glaucoma filtration surgery
Lockwood A; Brocchini S; Khaw PT
Current opinion in pharmacology 2013; 13: 65-71
